Siga Technologies (SIGA) Net Income towards Common Stockholders (QoQ) (2010 - 2025)
Siga Technologies (SIGA) Net Income towards Common Stockholders (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Siga Technologies | 212.67 Mn | 57.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -117.95% |
| Jun 30, 2025 | 9,676.33% |
| Mar 31, 2025 | -100.81% |
| Dec 31, 2024 | 3,304.92% |
| Sep 30, 2024 | -25.25% |
| Jun 30, 2024 | -82.51% |
| Mar 31, 2024 | -85.78% |
| Dec 31, 2023 | 18,482.57% |
| Sep 30, 2023 | 86.33% |
| Jun 30, 2023 | -213.34% |
| Mar 31, 2023 | -13.04% |
| Dec 31, 2022 | -102.46% |
| Sep 30, 2022 | 1,562.42% |
| Jun 30, 2022 | 650.48% |
| Mar 31, 2022 | -100.49% |
| Dec 31, 2021 | 2,457.06% |
| Sep 30, 2021 | -1,102.40% |
| Jun 30, 2021 | 85.04% |
| Mar 31, 2021 | -108.59% |
| Dec 31, 2020 | -16.65% |